Publications by authors named "Alan Horwich"

Claim this Profile
C
Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250].
J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, H Maxim Bruins, Theo M De Reijke, Alan Horwich

Eur Urol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.
J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, H Maxim Bruins, Theo M De Reijke, Alan Horwich

Eur Urol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013.
Mary Gleeson, Eliza A Hawkes, Clare Peckitt, Andrew Wotherspoon, Ayoma Attygalle, Alan Horwich

Leuk Lymphoma· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment.
Shaista Hafeez, Fiona McDonald, Susan Lalondrelle, Helen McNair, Karole Warren-Oseni, Alan Horwich

Int J Radiat Oncol Biol Phys· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer.
Shaista Hafeez, Karole Warren-Oseni, Helen A McNair, Vibeke N Hansen, Kelly Jones, Alan Horwich

Int J Radiat Oncol Biol Phys· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Surveillance versus Adjuvant Treatment in Stage I Germ Cell Tumors: Outcomes and Challenges.
Alan Horwich

Am Soc Clin Oncol Educ Book· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines on Testicular Cancer: 2015 Update.
Peter Albers, Walter Albrecht, Ferran Algaba, Carsten Bokemeyer, Gabriella Cohn-Cedermark, Alan Horwich

Eur Urol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of 18F-FDG PET/CT in the management of testicular cancers.
Gary J Cook, Aslam Sohaib, Robert A Huddart, David P Dearnaley, Alan Horwich

Nucl Med Commun· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma.
Sarah Barton, Eliza A Hawkes, David Cunningham, Clare Peckitt, Sue Chua, Alan Horwich

Eur J Haematol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of premature menopause after treatment for Hodgkin's lymphoma.
Anthony J Swerdlow, Rosie Cooke, Andrew Bates, David Cunningham, Stephen J Falk, Alan Horwich

J Natl Cancer Inst· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma.
Eliza A Hawkes, Sarah Barton, David Cunningham, Clare Peckitt, Sue Chua, Alan Horwich

Ann Hematol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated chemotherapy for germ cell cancer.
Alan Horwich

Ann Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medium-term outcomes of active surveillance for localised prostate cancer.
Elizabeth D Selvadurai, Mausam Singhera, Karen Thomas, Kabir Mohammed, Ruth Woode-Amissah, Alan Horwich

Eur Urol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testicular germ cell tumours.
Alan Horwich, David Nicol, Robert Huddart

BMJ· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
Rosalind A Eeles, Ali Amin Al Olama, Sara Benlloch, Edward J Saunders, Daniel A Leongamornlert, Alan Horwich

Nat Genet· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Seminoma stage 1: Patterns of care in Europe.
Susanne Osanto, Carla Vossen, Alan Horwich, Gedske Daugaard, Hendrik Van Poppel

BJU Int· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
Ali Amin Al Olama, Zsofia Kote-Jarai, Fredrick R Schumacher, Fredrik Wiklund, Sonja I Berndt, Alan Horwich

Hum Mol Genet· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diethylstilbestrol in castration-resistant prostate cancer.
Anna Wilkins, Mehdi Shahidi, Chris Parker, Ranga Gunapala, Karen Thomas, Alan Horwich

BJU Int· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of care in the management of seminoma stage I: results from a European survey.
Carla Y Vossen, Alan Horwich, Gedske Daugaard, Hein van Poppel, Susanne Osanto

BJU Int· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study.
Anthony J Swerdlow, Rosie Cooke, Andrew Bates, David Cunningham, Stephen J Falk, Alan Horwich

J Clin Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature.
Fabio Calabrò, Peter Albers, Carsten Bokemeyer, Chris Martin, Lawrence H Einhorn, Alan Horwich

Eur Urol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimizing toxicity in early-stage testicular cancer treatment.
Mausam Singhera, Kathryn Lees, Robert Huddart, Alan Horwich

Expert Rev Anticancer Ther· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.
David Dearnaley, Isabel Syndikus, Georges Sumo, Margaret Bidmead, David Bloomfield, Alan Horwich

Lancet Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.
Anthony J Swerdlow, Craig D Higgins, Paul Smith, David Cunningham, Barry W Hancock, Alan Horwich

J Clin Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage therapy: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
Alan Horwich, Gedske Daugaard, Christian Kollmannsberger, Joerg Beyer, Michael A S Jewett

Urology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis